| For: | Li J, Wang F, Zhang HJ, Sheng JQ, Yan WF, Ma MX, Fan RY, Gu F, Li CF, Chen DF, Zheng P, Gu YP, Cao Q, Yang H, Qian JM, Hu PJ, Xia B. Corticosteroid therapy in ulcerative colitis: Clinical response and predictors. World J Gastroenterol 2015; 21(10): 3005-3015 [PMID: 25780299 DOI: 10.3748/wjg.v21.i10.3005] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i10/3005.htm |
| Number | Citing Articles |
| 1 |
Zhaobei Cai, Shu Wang, Jiannan Li. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.765474
|
| 2 |
Cristina Ribeiro de Barros Cardoso, Amanda de Castro Habka, Camila Figueiredo Pinzan, Camilla Narjara Simão Oliveira, Jefferson Luiz da Silva, Murillo Duarte-Silva. Biological Therapy for Inflammatory Bowel Disease. 2020; doi: 10.5772/intechopen.90009
|
| 3 |
Zhen-Huan Yang, Fang Liu, Xiao-Ran Zhu, Fei-Ya Suo, Zi-jun Jia, Shu-Kun Yao. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World Journal of Gastroenterology 2021; 27(24): 3609-3629 doi: 10.3748/wjg.v27.i24.3609
|
| 4 |
Mona A. Mohammed, Bassant M. M. Ibrahim, Yasmin Abdel-Latif, Azza H. Hassan, Mohamed A. El Raey, Emad M. Hassan, Souad E. El-Gengaihi. Pharmacological and metabolomic profiles of Musa acuminata wastes as a new potential source of anti-ulcerative colitis agents. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14599-8
|
| 5 |
Kate E. Lee, Adam S. Faye, Séverine Vermeire, Bo Shen. Perioperative Management of Ulcerative Colitis: A Systematic Review. Diseases of the Colon & Rectum 2022; doi: 10.1097/DCR.0000000000002588
|
| 6 |
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1107976
|
| 7 |
Koroush Ghanadi, Javad Valizadeh, Afshin Hasanvand. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3248-4
|
| 8 |
Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis. Biomaterials Advances 2023; 148 doi: 10.1016/j.bioadv.2023.213383
|
| 9 |
Eva Barreiro-Alonso, Cristina Saro-Gismera, Manuel Sánchez. Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments. Expert Review of Gastroenterology & Hepatology 2018; 12(7) doi: 10.1080/17474124.2018.1489231
|
| 10 |
Li-Hong Hu, Yu-Jing Fan, Qing Li, Jing-Ming Guan, Bo Qu, Feng-Hua Pei, Bing-Rong Liu. Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice. Molecular Medicine Reports 2017; 15(6) doi: 10.3892/mmr.2017.6524
|
| 11 |
Mariana Roque Coelho, Marcela Diogo Romi, Daniele Masterson Tavares Pereira Ferreira, Cyrla Zaltman, Marcia Soares-Mota. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. Nutrients 2020; 12(8) doi: 10.3390/nu12082296
|
| 12 |
Arvin Haj-Mirzaian, Madeline Ma, Nicole Hofmann, Hushan Yuan, Umar Mahmood, Pedram Heidari. Granzyme B PET Imaging Uncovers Dynamic Patterns of Disease Activity and Therapeutic Response in a Murine Colitis Model. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104194
|
| 13 |
Fan Wang, Juerong Feng, Qian Gao, Minxing Ma, Xue Lin, Jing Liu, Jin Li, Qiu Zhao. Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies. Clinical Nutrition 2017; 36(5) doi: 10.1016/j.clnu.2016.10.009
|
| 14 |
Ling Zhao, Hai-tao Xiao, Huai-xue Mu, Tao Huang, Ze-si Lin, Linda Zhong, Guang-zhi Zeng, Bao-min Fan, Cheng-yuan Lin, Zhao-xiang Bian. Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice. Molecules 2017; 22(7) doi: 10.3390/molecules22071218
|
| 15 |
Shihao Duan, Yi Yang, Yubin Cao, Pingrun Chen, Chang Liang, Yan Zhang. Symptoms of anxiety and depression associated with steroid efficacy and clinical outcomes in patients with inflammatory bowel disease. Frontiers in Psychiatry 2023; 14 doi: 10.3389/fpsyt.2023.1029467
|
| 16 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231173331
|
| 17 |
Fan Wang, Xue Lin, Qiu Zhao, Jin Li. Fat intake and risk of ulcerative colitis: Systematic review and dose–response meta‐analysis of epidemiological studies. Journal of Gastroenterology and Hepatology 2017; 32(1) doi: 10.1111/jgh.13416
|
| 18 |
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23136966
|
| 19 |
Susmita Mondal, Monojit Das, Ria Ghosh, Manali Singh, Aniruddha Adhikari, Soumendra Darbar, Anjan Kumar Das, Siddhartha Sankar Bhattacharya, Debasish Pal, Debasish Bhattacharyya, Ahmed S. A. Ahmed, Asim Kumar Mallick, Munirah M. Al-Rooqi, Ziad Moussa, Saleh A. Ahmed, Samir Kumar Pal. Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-05023-6
|
| 20 |
Jia-Yan Nie, Qiu Zhao. Beverage consumption and risk of ulcerative colitis. Medicine 2017; 96(49) doi: 10.1097/MD.0000000000009070
|
| 21 |
Zhenhuan Yang, Wenjing Liu, Xuefeng Zhou, Xiaoran Zhu, Feiya Suo, Shukun Yao. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease. Medicine 2020; 99(43) doi: 10.1097/MD.0000000000022916
|
| 22 |
Acharya Balkrishna, Rani Singh, Vivek Gohel, Sagar Arora, Rishabh Dev, Kunal Bhattacharya, Anurag Varshney. Enteric-Coated Cologrit Tablet Exhibit Robust Anti-Inflammatory Response in Ulcerative Colitis-like In-Vitro Models by Attuning NFκB-Centric Signaling Axis. Pharmaceuticals 2022; 16(1) doi: 10.3390/ph16010063
|
| 23 |
Heike E.F. Becker, John Penders, Daisy M.A. E. Jonkers. Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations. Gastroenterology 2022; 162(1) doi: 10.1053/j.gastro.2021.07.050
|
| 24 |
Yusuke Miyatani, Tetsuro Takayama, Shinji Okabayashi, Toshiyuki Endo, Tomoe Tashiro, Aya Hojo, Kunio Asonuma, Shintaro Sagami, Toshifumi Hibi, Masaru Nakano, Taku Kobayashi. Exploratory Risk Patterns of Steroid Dependency in Ulcerative Colitis: A Multicenter Pilot Study Combining Logistic Regression and Self-Organizing Map Analysis. Inflammatory Intestinal Diseases 2026; 11(1) doi: 10.1159/000552947
|
| 25 |
Yuemin Feng, Junjie Huang, Jingzhi Gong, Weilong Peng, Chenglong Yu, Yuying Huai, Chaoyang Chen, Ruonan Bo, Mingjiang Liu, Jingui Li. Composition and anti-colitis efficacy analysis of ethanol and aqueous extraction of Moringa oleifera leaves. Fitoterapia 2025; 185 doi: 10.1016/j.fitote.2025.106720
|